| 國立臺灣大學 |
2007 |
Gemcitabine Is Preferentially Chemosensitive in Cyclin D1 or Cyclin E over-Expressing Human Gastric Cancer Cells
|
沈盈君; 鄭安理; SHEN, YING-CHUN; CHENG, ANN-LII |
| 國家衛生研究院 |
2015-07 |
Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review
|
Park, JO;Oh, DY;Hsu, C;Chen, JS;Chen, LT;Orlando, M;Kim, JS;Lim, HY |
| 臺大學術典藏 |
2022-08-19T00:20:46Z |
Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review
|
Lim H.Y.; Kim J.S.; Orlando M.; Chen L.-T.; Chen J.-S.; CHIUN HSU; Oh D.-Y.; Park J.O. |
| 臺大學術典藏 |
2015 |
Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review
|
Oh D.-Y.; Chiun Hsu; Chen J.-S.; Chen L.-T.; Orlando M.; Kim J.S.; Lim H.Y.; Park J.O.; Park J.O.;Oh D.-Y.;Chiun Hsu;Chen J.-S.;Chen L.-T.;Orlando M.;Kim J.S.;Lim H.Y. |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: A multicenter prospective Phase II trial
|
Hsieh J.C.; Hsu C.-L.; Ng S.-H.; Wang C.-H.; Lee K.-D.; Lu C.-H.; Chang Y.-F.; Hsieh R.-K.; KUN-HUEI YEH; Hsiao C.-H.; Chen S.-Y.; Shiau C.-Y.; Wang H.-M. |
| 國家衛生研究院 |
2008-12 |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu, C;Kuo, SH;Hu, FC;Cheng, AL;Shih, JY;Yu, CJ;Lin, CC;Huang, TC;Yang, PC;Yang, CH |
| 臺大學術典藏 |
2022-08-19T00:21:07Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
CHIUN HSU; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H. |
| 國立臺灣大學 |
2008 |
Gemcitabine Plus Conventional-Dose Epirubicin Versus Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Stage Iiib/Iv Non-Small Cell Lung Carcinoma-a Randomized Phase Ii Trial
|
許駿; 郭頌鑫; 胡賦强; 鄭安理; 施金元; 余忠仁; 林家齊; 楊泮池; 楊志新; HSU, CHIUN; KUO, SUNG-HSIN; HU, FU-CHANG; CHENG, ANN-LII; SHIH, JIN-YUAN; YU, CHONG-JEN; LIN, CHIA-CHI; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2020-04-10T12:51:22Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Huang T.-C.; Yang P.-C.; Yang C.-H.; Lin C.-C.; Chiun Hsu; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-05-25T07:35:30Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C; Kuo S.-H; Hu F.-C; Cheng A.-L; Shih J.-Y; Yu C.-J; Chia-Chi Lin; Huang T.-C; Yang P.-C; Yang C.-H. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Lin C.-C; Huang T.-C; Yang P.-C; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Cheng A.-L; Hu F.-C; Kuo S.-H; Hsu C; Chih-Hsin Yang;Yang P.-C;Huang T.-C;Lin C.-C;Yu C.-J;Shih J.-Y;Cheng A.-L;Hu F.-C;Kuo S.-H;Hsu C |
| 臺大學術典藏 |
2020-08-13T06:33:59Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Yang C.-H.; Yang P.-C.; Huang T.-C.; Lin C.-C.; Yu C.-J.; Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-12-02T02:34:30Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; PAN-CHYR YANG; Yang C.-H. |
| 臺大學術典藏 |
2021-02-23T08:26:37Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C.; SUNG-HSIN KUO; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-09-01T01:54:26Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2022-06-27T07:07:53Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; CHONG-JEN YU; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2018-09-10T06:52:59Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial
|
Chiun Hsu and Sung-Hsin Kuo and Fu-Chang Hu and Ann-Lii Cheng and Jin-Yuan Shih and Chong-Jen Yu and Chia-Chi Lin and Tsu-Chen Huang and Pan-Chyr Yang and Chih-Hsin Yang; Chong-Jen Yu; Sung-Hsin Kuo; JIN-YUAN SHIH; ANN-LII CHENG |
| 國家衛生研究院 |
2015-11 |
Gemcitabine synergistically enhances anti-tumor effects of recombinant immunogen-based cancer immunotherapy
|
Liu, SJ;Chang, LS;Yan, WL;Yeh, YC;Leng, CH |
| 國家衛生研究院 |
1997-05 |
Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study
|
Perng, RP; Chen, YM; MingLiu, J; Tsai, CM; Lin, WC; Yang, KY; WhangPeng, J |
| 臺大學術典藏 |
2021-02-23T08:26:35Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
Yang S.-H.; Lin Z.-Z.; SUNG-HSIN KUO; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:07Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:51Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
Yang S.-H.; ZHONG-ZHE LIN; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:20Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
Yang S.-H.; Lin Z.-Z.; Kuo S.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-12T04:01:31Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
YANG SHIH-HUNG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-03-08T03:44:08Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2022-06-10T06:11:13Z |
Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma
|
Yang S.-H.; ZHONG-ZHE LIN; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2018-09-10T03:52:56Z |
Gemcitabine-induced acute lipodermatosclerosis-like reaction
|
Chu, C.-Y. and Yang, C.-H. and Chiu, H.-C.; HSIEN-CHING CHIU; CHIA-YU CHU |
| 國立臺灣大學 |
2001 |
Gemcitabine-Induced Acute Lipodermatosclerosis-Like Reaction
|
朱家瑜; 楊志新; 邱顯清; CHU, CHIA-YU; YANG, CHIH-HSIN; CHIU, HSIEN-CHING |
| 臺大學術典藏 |
2019-12-04T08:44:23Z |
Gemcitabine-induced acute lipodermatosclerosis-like reaction
|
Chia-Yu Chu;Yang C.-H.;Chiu H.-C.; CHIA-YU CHU; Yang C.-H.; Chiu H.-C. |
| 臺大學術典藏 |
2019-12-05T06:27:02Z |
Gemcitabine-induced acute lipodermatosclerosis-like reaction
|
Chu C.-Y.;Yang C.-H.;Hsien-Ching Chiu; Chu C.-Y.; Yang C.-H.; HSIEN-CHING CHIU |
| 臺大學術典藏 |
2020-05-26T09:27:32Z |
Gemcitabine-induced acute lipodermatosclerosis-like reaction
|
Chu C.-Y;Chih-Hsin Yang;Chiu H.-C.; Chu C.-Y; CHIH-HSIN YANG; Chiu H.-C. |
| 國立成功大學 |
2021-07-8 |
Gemcitabine-induced Gli-dependent activation of hedgehog pathway resists to the treatment of urothelial carcinoma cells
|
Chang;Yu-Hao;Tam;Hoi-Lam;Lu;Meng-Chien;Huang;Huei-Sheng |
| 臺北醫學大學 |
2005 |
Gemcitabine/Carboplatin Chemotherapy for pure small cell carcinoma of the prostate: A case report.
|
朱娟秀; Chen KC; Chiu AW; Chiang HS; Chu JS; Cheng CJ; |
| 高雄醫學大學 |
2012 |
gemcitabine在膀胱癌細胞中降解cyclin D1的機轉
|
徐偉齊;高于婷;侯自銓;蒲永孝;黃阿梅 |
| 國立交通大學 |
2014-12-08T15:39:12Z |
GEMDOCK: A generic evolutionary method for molecular docking
|
Yang, JM; Chen, CC |
| 國立交通大學 |
2014-12-12T02:09:22Z |
GEMDOCK之驗證與應用以及資料融合在虛擬藥物篩選之應用
|
陳彥甫; Yan-Fu Chen; 楊進木; Jinn-Moon Yang |
| 國立交通大學 |
2014-12-12T02:16:44Z |
GEMDOCK於虛擬藥物資料庫篩選之功能增進及套膜蛋白與醯亞胺水解酵素之實際應用
|
沈再威; Tsai-Wei Shen; 楊進木; Jinn-Moon Yang |
| 臺北醫學大學 |
2009-12 |
GEMD® / 脂福®錠
|
藥劑部 |
| 中原大學 |
2008-10 |
GEMEET能源政策模型與MARKAL能源工程模型之整合與評估
|
林師模;蘇漢邦;葛復光;林晉勗;盧樂人 |
| 淡江大學 |
2025-11-18 |
Gemeinschaftsbildung unter den Deutschen in der „Musterkolonie Kiautschou“ und deren Auswirkungen auf die lokale Kultur
|
Schoen, Michael |
| 臺大學術典藏 |
2018-09-10T06:04:07Z |
Gemeinsinn und das Schöne als Symbol des Sittlichen (Common Sense and Beauty as Symbol of Morality)
|
Wenzel Christian Helmut; CHRISTIAN HELMUT WENZEL; CHRISTIAN HELMUT WENZEL |
| 國立臺灣大學 |
2014 |
Gemella parahaemolysans sp nov and Gemella taiwanensis sp nov., isolated from human clinical specimens
|
Hung, Wei-Chun; Chen, Hsiao-Jan; Tsai, Jui-Chang; Tseng, Sung-Pin; Lee, Tai-Fen; Hsueh, Po-Ren; Shieh, Wung Yang; Teng, Lee-Jene; 蔡瑞章; 薛博仁; 鄧麗珍; 李岱芬 |
| 臺大學術典藏 |
2018-09-10T14:56:38Z |
Gemella parahaemolysans sp. nov. and Gemella taiwanensis sp. nov., isolated from human clinical specimens
|
Hung, W.-C. and Chen, H.-J. and Tsai, J.-C. and Tseng, S.-P. and Lee, T.-F. and Hsueh, P.-R. and Shieh, W.Y. and Teng, L.-J.; Hung, Wei-Chun;Chen, Hsiao-Jan;Tsai, Jui-Chang;Tseng, Sung-Pin;Lee, Tai-Fen;Hsueh, Po-Ren;Shieh, Wung Yang;Teng, Lee-Jene; 蔡瑞章;薛博仁;鄧麗珍;李岱芬; PO-REN HSUEH; Hung, Wei-Chun; JUI-CHANG TSAI; Chen, Hsiao-Jan; Tsai, Jui-Chang; Tsai, Jui-Chang; WUNG YANG SHIEH; LEE-JENE TENG; Tseng, Sung-Pin; Lee, Tai-Fen; Lee, Tai-Fen; Hsueh, Po-Ren; Hsueh, Po-Ren; Shieh, Wung Yang; Shieh, Wung Yang; Teng, Lee-Jene; Teng, Lee-Jene |
| 臺大學術典藏 |
2020-03-27T05:29:04Z |
Gemella parahaemolysans sp. nov. and Gemella taiwanensis sp. nov., isolated from human clinical specimens
|
Teng L.-J.; Shieh W.Y.; PO-REN HSUEH; Lee T.-F.; Tseng S.-P.; Chen H.-J.; Tsai J.-C.; Hung W.-C.; Teng L.-J.;Shieh W.Y.;PO-REN HSUEH;Lee T.-F.;Tseng S.-P.;Tsai J.-C.;Chen H.-J.;Hung W.-C. |
| 臺大學術典藏 |
2020-06-30T06:13:25Z |
Gemella parahaemolysans sp. nov. and Gemella taiwanensis sp. nov., isolated from human clinical specimens
|
Hung W.-C.;Chen H.-J.;Tsai J.-C.;Tseng S.-P.;Lee T.-F.;Hsueh P.-R.;Shieh W.Y.;Lee-Jene Teng; Hung W.-C.; Chen H.-J.; Tsai J.-C.; Tseng S.-P.; Lee T.-F.; Hsueh P.-R.; Shieh W.Y.; LEE-JENE TENG |
| 臺大學術典藏 |
2014 |
Gemella parahaemolysans sp. nov. and Gemella taiwanensis sp. nov., isolated from human clinical specimens
|
Tseng S.-P.; Tsai J.-C.; Chen H.-J.; Hung W.-C.; Hung W.-C.;Chen H.-J.;Tsai J.-C.;Tseng S.-P.;Lee T.-F.;Po-Ren Hsueh;Shieh W.Y.;Teng L.-J.; Lee T.-F.; PO-REN HSUEH; Shieh W.Y.; Teng L.-J. |
| 高雄醫學大學 |
2014 |
Gemella parahaemolysans sp. nov. and Gemella taiwanensis sp. nov., isolated from human clinical specimens
|
洪薇鈞;Chen, HJ;Tsai, JC;曾嵩斌;Lee, TF;Hsueh, PR;Shieh, WY;LJ , Teng; Hung, WC;Chen, HJ;Tsai, JC;Tseng, SP;Lee, TF;Hsueh, PR;Shieh, WY;LJ , Teng |
| 國立臺灣大學 |
2001 |
Gemfibrozil Treatment Potentiates Oxidative Resistance of High-Density Lipoprotein in Hypertriglyceridemic Patients
|
陳明豐; 王宗道; 李源德; 葉顯堂; 許秀卿; CHEN, MING-FONG; WANG, TZUNG-DAU; LEE, YUAN-TEH; YEH, HSIEN-TANG; HSU, HSIU-CHING |
| 臺大學術典藏 |
2020-12-01T08:29:39Z |
Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients
|
Chen M.-F.; TZUNG-DAU WANG; Yeh H.-T.; Hsu H.-C.; Lee Y.-T. |
| 國立成功大學 |
2012-06 |
Gemifloxacin Can Partially Overcome Quinolone Resistance of H. pylori with gyrA Mutation in Taiwan
|
Chang, Wei-Lun; Kao, Cheng-Yen; Wu, Chung-Tai; Huang, Ay-Huey; Wu, Jiunn-Jong; Yang, Hsiao-Bai; Cheng, Hsiu-Chi; Sheu, Bor-Shyang |
